FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022773941> ?p ?o ?g. }

• W2022773941 endingPage "441" @default.
• W2022773941 startingPage "432" @default.
• W2022773941 abstract "The authors investigated the in vivo anti-tumor effect of intratumoral administration of bone marrow-derived dendritic cells (DCs) after chemotherapy using an oral fluoropyrimidine anti-cancer drug TS-1, and followed by immunotherapeutic agent OK-432, in two syngeneic tumor-bearing mouse models. Both in Meth-A fibrosarcoma-bearing BALB/c mice and in SCCVII-bearing C3H/HeN mice, 1 week of oral administration of TS-1 effected partial eradication of established tumors. Intratumoral injection of DCs and OK-432 caused only slight inhibition of the tumor growth. However, TS-1 administration followed by DCs and OK-432 resulted in a marked inhibition in the tumor growth and also contributed to a greater prolongation of survival. By the injection of DCs and OK-432 after TS-1 administration, a significant infiltration of immune cells, especially CD8+ T cells, was observed. Furthermore, the cytotoxic activities of tumor-infiltrating lymphocytes and draining lymph node cells against inoculated tumor cells were significantly increased by the therapy, while activities against nonspecific target cells were not. Cytotoxic memory T cells were also induced; the main effectors were MHC class I-restricted, CD8+ T cells. The same therapy was also applied to SCCVII-bearing C3H/HeJ mice in which the Toll-like receptor (TLR) 4 is mutated and its function impaired; no immunotherapeutic effect was observed in the TLR4-deficient mouse model. These findings suggest that the local DC therapy in combination with TS-1 and OK-432 may be a useful strategy for the treatment of solid tumors, and that TLR4 signaling is involved in the success of this therapy." @default.
• W2022773941 created "2016-06-24" @default.
• W2022773941 creator A5003219785 @default.
• W2022773941 creator A5009141167 @default.
• W2022773941 creator A5028092189 @default.
• W2022773941 creator A5030873090 @default.
• W2022773941 creator A5031869510 @default.
• W2022773941 creator A5033962576 @default.
• W2022773941 creator A5040452650 @default.
• W2022773941 creator A5053969602 @default.
• W2022773941 creator A5056411544 @default.
• W2022773941 creator A5060323942 @default.
• W2022773941 creator A5070590061 @default.
• W2022773941 creator A5086544310 @default.
• W2022773941 date "2004-11-01" @default.
• W2022773941 modified "2023-09-27" @default.
• W2022773941 title "Anti-Tumor Effect of an Intratumoral Administration of Dendritic Cells in Combination with TS-1, an Oral Fluoropyrimidine Anti-Cancer Drug, and OK-432, a Streptococcal Immunopotentiator" @default.
• W2022773941 cites W1561591381 @default.
• W2022773941 cites W1577698383 @default.
• W2022773941 cites W1583569488 @default.
• W2022773941 cites W1661544713 @default.
• W2022773941 cites W1930598094 @default.
• W2022773941 cites W1964416857 @default.
• W2022773941 cites W1965567407 @default.
• W2022773941 cites W1968006592 @default.
• W2022773941 cites W1972356957 @default.
• W2022773941 cites W1978926805 @default.
• W2022773941 cites W1983467202 @default.
• W2022773941 cites W1994764115 @default.
• W2022773941 cites W2002579474 @default.
• W2022773941 cites W2017883909 @default.
• W2022773941 cites W2032540605 @default.
• W2022773941 cites W2039713566 @default.
• W2022773941 cites W2041805971 @default.
• W2022773941 cites W2046671679 @default.
• W2022773941 cites W2049197565 @default.
• W2022773941 cites W2060123485 @default.
• W2022773941 cites W2062583330 @default.
• W2022773941 cites W2077902459 @default.
• W2022773941 cites W2095833996 @default.
• W2022773941 cites W2106315208 @default.
• W2022773941 cites W2111220263 @default.
• W2022773941 cites W2122018992 @default.
• W2022773941 cites W2126200259 @default.
• W2022773941 cites W2129319296 @default.
• W2022773941 cites W2129852738 @default.
• W2022773941 cites W2149289168 @default.
• W2022773941 cites W2152627678 @default.
• W2022773941 cites W2156040418 @default.
• W2022773941 cites W2171260427 @default.
• W2022773941 cites W2177327503 @default.
• W2022773941 cites W2330197116 @default.
• W2022773941 cites W79103059 @default.
• W2022773941 doi "https://doi.org/10.1097/00002371-200411000-00003" @default.
• W2022773941 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15534487" @default.
• W2022773941 hasPublicationYear "2004" @default.
• W2022773941 type Work @default.
• W2022773941 sameAs 2022773941 @default.
• W2022773941 citedByCount "33" @default.
• W2022773941 countsByYear W20227739412012 @default.
• W2022773941 countsByYear W20227739412013 @default.
• W2022773941 countsByYear W20227739412016 @default.
• W2022773941 countsByYear W20227739412018 @default.
• W2022773941 crossrefType "journal-article" @default.
• W2022773941 hasAuthorship W2022773941A5003219785 @default.
• W2022773941 hasAuthorship W2022773941A5009141167 @default.
• W2022773941 hasAuthorship W2022773941A5028092189 @default.
• W2022773941 hasAuthorship W2022773941A5030873090 @default.
• W2022773941 hasAuthorship W2022773941A5031869510 @default.
• W2022773941 hasAuthorship W2022773941A5033962576 @default.
• W2022773941 hasAuthorship W2022773941A5040452650 @default.
• W2022773941 hasAuthorship W2022773941A5053969602 @default.
• W2022773941 hasAuthorship W2022773941A5056411544 @default.
• W2022773941 hasAuthorship W2022773941A5060323942 @default.
• W2022773941 hasAuthorship W2022773941A5070590061 @default.
• W2022773941 hasAuthorship W2022773941A5086544310 @default.
• W2022773941 hasConcept C142724271 @default.
• W2022773941 hasConcept C154317977 @default.
• W2022773941 hasConcept C167672396 @default.
• W2022773941 hasConcept C185592680 @default.
• W2022773941 hasConcept C202751555 @default.
• W2022773941 hasConcept C203014093 @default.
• W2022773941 hasConcept C2776495794 @default.
• W2022773941 hasConcept C2776999253 @default.
• W2022773941 hasConcept C2777701055 @default.
• W2022773941 hasConcept C502942594 @default.
• W2022773941 hasConcept C55493867 @default.
• W2022773941 hasConcept C71924100 @default.
• W2022773941 hasConcept C8891405 @default.
• W2022773941 hasConcept C98274493 @default.
• W2022773941 hasConceptScore W2022773941C142724271 @default.
• W2022773941 hasConceptScore W2022773941C154317977 @default.
• W2022773941 hasConceptScore W2022773941C167672396 @default.
• W2022773941 hasConceptScore W2022773941C185592680 @default.
• W2022773941 hasConceptScore W2022773941C202751555 @default.
• W2022773941 hasConceptScore W2022773941C203014093 @default.
• W2022773941 hasConceptScore W2022773941C2776495794 @default.
• W2022773941 hasConceptScore W2022773941C2776999253 @default.

• next